132 related articles for article (PubMed ID: 37857324)
1. Receptor Interacting Ser/Thr-Protein Kinase 2 as a New Therapeutic Target.
Rivoal M; Dubuquoy L; Millet R; Leleu-Chavain N
J Med Chem; 2023 Nov; 66(21):14391-14410. PubMed ID: 37857324
[TBL] [Abstract][Full Text] [Related]
2. 14-3-3 and erlin proteins differentially interact with RIPK2 complexes.
Steinle H; Ellwanger K; Mirza N; Briese S; Kienes I; Pfannstiel J; Kufer TA
J Cell Sci; 2021 Jun; 134(12):. PubMed ID: 34152391
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors.
Canning P; Ruan Q; Schwerd T; Hrdinka M; Maki JL; Saleh D; Suebsuwong C; Ray S; Brennan PE; Cuny GD; Uhlig HH; Gyrd-Hansen M; Degterev A; Bullock AN
Chem Biol; 2015 Sep; 22(9):1174-84. PubMed ID: 26320862
[TBL] [Abstract][Full Text] [Related]
4. Transcription of NOD1 and NOD2 and their interaction with CARD9 and RIPK2 in IFN signaling in a perciform fish, the Chinese perch,
Peng XY; Wang KL; Li L; Li B; Wu XY; Zhang ZW; Li N; Liu LH; Nie P; Chen SN
Front Immunol; 2024; 15():1374368. PubMed ID: 38715616
[TBL] [Abstract][Full Text] [Related]
5. Assaying RIPK2 Activation by Complex Formation.
Steinle H; Ellwanger K; Kufer TA
Methods Mol Biol; 2022; 2523():133-150. PubMed ID: 35759195
[TBL] [Abstract][Full Text] [Related]
6. Postbiotics for NOD2 require nonhematopoietic RIPK2 to improve blood glucose and metabolic inflammation in mice.
Cavallari JF; Barra NG; Foley KP; Lee A; Duggan BM; Henriksbo BD; Anhê FF; Ashkar AA; Schertzer JD
Am J Physiol Endocrinol Metab; 2020 Apr; 318(4):E579-E585. PubMed ID: 32101030
[TBL] [Abstract][Full Text] [Related]
7. A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation.
Hasegawa M; Fujimoto Y; Lucas PC; Nakano H; Fukase K; Núñez G; Inohara N
EMBO J; 2008 Jan; 27(2):373-83. PubMed ID: 18079694
[TBL] [Abstract][Full Text] [Related]
8. A regulatory region on RIPK2 is required for XIAP binding and NOD signaling activity.
Heim VJ; Dagley LF; Stafford CA; Hansen FM; Clayer E; Bankovacki A; Webb AI; Lucet IS; Silke J; Nachbur U
EMBO Rep; 2020 Nov; 21(11):e50400. PubMed ID: 32954645
[TBL] [Abstract][Full Text] [Related]
9. Activation of RIPK2-mediated NOD1 signaling promotes proliferation and invasion of ovarian cancer cells via NF-κB pathway.
Zhang W; Wang Y
Histochem Cell Biol; 2022 Feb; 157(2):173-182. PubMed ID: 34825931
[TBL] [Abstract][Full Text] [Related]
10. Asparagine attenuates hepatic injury caused by lipopolysaccharide in weaned piglets associated with modulation of Toll-like receptor 4 and nucleotide-binding oligomerisation domain protein signalling and their negative regulators.
Wu H; Liu Y; Pi D; Leng W; Zhu H; Hou Y; Li S; Shi H; Wang X
Br J Nutr; 2015 Jul; 114(2):189-201. PubMed ID: 26079268
[TBL] [Abstract][Full Text] [Related]
11. Small molecule inhibitors reveal an indispensable scaffolding role of RIPK2 in NOD2 signaling.
Hrdinka M; Schlicher L; Dai B; Pinkas DM; Bufton JC; Picaud S; Ward JA; Rogers C; Suebsuwong C; Nikhar S; Cuny GD; Huber KV; Filippakopoulos P; Bullock AN; Degterev A; Gyrd-Hansen M
EMBO J; 2018 Sep; 37(17):. PubMed ID: 30026309
[TBL] [Abstract][Full Text] [Related]
12. RIPK2 NODs to XIAP and IBD.
Topal Y; Gyrd-Hansen M
Semin Cell Dev Biol; 2021 Jan; 109():144-150. PubMed ID: 32631784
[TBL] [Abstract][Full Text] [Related]
13. Activation of the nucleotide oligomerization domain signaling pathway by the non-bacterially derived xanthone drug 5'6-dimethylxanthenone-4-acetic acid (Vadimezan).
Cheng G; Sun J; Fridlender ZG; Wang LC; Ching LM; Albelda SM
J Biol Chem; 2010 Apr; 285(14):10553-62. PubMed ID: 20118240
[TBL] [Abstract][Full Text] [Related]
14. Nod2 and Rip2 contribute to innate immune responses in mouse neutrophils.
Jeong YJ; Kang MJ; Lee SJ; Kim CH; Kim JC; Kim TH; Kim DJ; Kim D; Núñez G; Park JH
Immunology; 2014 Oct; 143(2):269-76. PubMed ID: 24766550
[TBL] [Abstract][Full Text] [Related]
15. Increased NOD1, but not NOD2, activity in subcutaneous adipose tissue from patients with metabolic syndrome.
Zhou YJ; Liu C; Li CL; Song YL; Tang YS; Zhou H; Li A; Li Y; Weng Y; Zheng FP
Obesity (Silver Spring); 2015 Jul; 23(7):1394-400. PubMed ID: 26052894
[TBL] [Abstract][Full Text] [Related]
16. XIAP mediates NOD signaling via interaction with RIP2.
Krieg A; Correa RG; Garrison JB; Le Negrate G; Welsh K; Huang Z; Knoefel WT; Reed JC
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14524-9. PubMed ID: 19667203
[TBL] [Abstract][Full Text] [Related]
17. Design of pyrido[2,3-d]pyrimidin-7-one inhibitors of receptor interacting protein kinase-2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling.
Nikhar S; Siokas I; Schlicher L; Lee S; Gyrd-Hansen M; Degterev A; Cuny GD
Eur J Med Chem; 2021 Apr; 215():113252. PubMed ID: 33601309
[TBL] [Abstract][Full Text] [Related]
18. Activation of NOD receptors by Neisseria gonorrhoeae modulates the innate immune response.
Mavrogiorgos N; Mekasha S; Yang Y; Kelliher MA; Ingalls RR
Innate Immun; 2014 May; 20(4):377-89. PubMed ID: 23884094
[TBL] [Abstract][Full Text] [Related]
19. The cytosolic sensors Nod1 and Nod2 are critical for bacterial recognition and host defense after exposure to Toll-like receptor ligands.
Kim YG; Park JH; Shaw MH; Franchi L; Inohara N; Núñez G
Immunity; 2008 Feb; 28(2):246-57. PubMed ID: 18261938
[TBL] [Abstract][Full Text] [Related]
20. Role of nucleotide-binding oligomerization domain 1 (NOD1) in pericyte-mediated vascular inflammation.
Navarro R; Delgado-Wicke P; Nuñez-Prado N; Compte M; Blanco-Toribio A; Nuñez G; Álvarez-Vallina L; Sanz L
J Cell Mol Med; 2016 May; 20(5):980-6. PubMed ID: 26915562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]